Login
$BCAX
$9.70 -$0.32 (3.19%) Live

Company Executives

Officer Age In this role 2025 pay Source
Ryan Cohlhepp Also a director
President, COO & Interim CEO
Title from the Form 4 dated Sep 8, 2026
49 Not stated $858,400
Claire Mazumdar Also a director
Chief Executive Officer
Title from the Form 4 dated Aug 10, 2026
36 Not stated $927,688
Ivan Hyep
Chief Financial Officer and Treasurer
41 Not stated Not reported
Jennifer Larson
Chief Financial Officer
Title from the Form 4 dated Aug 12, 2026
Not stated Not stated Not reported
Lara Meisner
Chief Legal Officer, Compliance Officer and Corporate Secretary
54 Not stated Not reported
David Raben
Chief Medical Officer
62 Since 2023
3 years
$709,164
William Schelman
Chief Medical Officer
Title from the Form 4 dated May 8, 2026
Not stated Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Apr 27, 2026 · updated by the 8-K of Jul 28, 2026

Directors
11
serving now
Independent
9 of 11
stated in the proxy
Average tenure
3.4 years
from year joined
CEO also chairs the board
No
Michael Powell
Director Age On board Independent Committees Other public boards 2025 pay Source
Michael Powell
71 2024
2 years
Independent
Audit Committee
None stated Not stated
Claire Mazumdar
36 2020
6 years
Not independent None stated Relay Therapeutics, Inc. Paid as CEO
Ryan Cohlhepp
49 2024
2 years
Not independent None stated None stated Not stated
Christopher Bowden
65 2024
2 years
Independent
Compensation Committee
None stated $253,634
Carolyn Ng
42 2023
3 years
Independent
Audit Committee Nominating and Corporate Governance Committee
None stated Not stated
Jake Simson
40 2023
3 years
Independent
Nominating and Corporate Governance Committee
Tyra Biosciences, Inc., Septerna, Inc., Janux Therapeutics, Inc. Not stated
Kate Haviland
50 2023
3 years
Independent
Compensation Committee Launch Readiness Committee · Chair
Fulcrum Therapeutics, Inc. $253,634
Scott Robertson
46 2023
3 years
Independent
Audit Committee · Chair
None stated $263,634
Jeremy Bender Joined Jul 28, 2026
- - Independent
Audit Committee Launch Readiness Committee
- -
Christy Oliger Joined Jul 28, 2026
- - Independent
Nominating and Corporate Governance Committee Launch Readiness Committee
- -
Nils Lonberg Leaving at the meeting
70 2019
7 years
Independent None stated None stated Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.

No related-party transactions disclosed

The proxy filed Apr 27, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support